Maynard Um
-
-
-
-
-
-
-
Cellectar Biosciences (CLRB) Misses Q2 EPS by 326c
-
-
-
-
-
-
-
Cellectar Biosciences (CLRB) Granted FDA Breakthrough Therapy Designation for Iopofosine I 131
-
-
-
-
-
-
-
Cellectar Biosciences (CLRB) Misses Q3 EPS by 7c
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

